704 related articles for article (PubMed ID: 31888654)
1. Antiplasmodial profile of selected compounds from Malaria Box: in vitro evaluation, speed of action and drug combination studies.
de Souza GE; Bueno RV; de Souza JO; Zanini CL; Cruz FC; Oliva G; Guido RVC; Aguiar ACC
Malar J; 2019 Dec; 18(1):447. PubMed ID: 31888654
[TBL] [Abstract][Full Text] [Related]
2. Antiplasmodial Activity Assay of 3-Chloro-4-(4-chlorophenoxy) Aniline Combinations with Artesunate or Chloroquine
Wekesa Sifuna M; Wambui M; Kang'ethe Nganga J; Wainaina Kariuki D; Kimani FT; Muregi FW
Biomed Res Int; 2019; 2019():5153482. PubMed ID: 31781619
[TBL] [Abstract][Full Text] [Related]
3. Antiplasmodial efficacy of
Satish PVV; Kumari DS; Sunita K
J Vector Borne Dis; 2017; 54(3):215-225. PubMed ID: 29097636
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo anti-malarial activity of plants from the Brazilian Amazon.
Lima RB; Rocha e Silva LF; Melo MR; Costa JS; Picanço NS; Lima ES; Vasconcellos MC; Boleti AP; Santos JM; Amorim RC; Chaves FC; Coutinho JP; Tadei WP; Krettli AU; Pohlit AM
Malar J; 2015 Dec; 14():508. PubMed ID: 26682750
[TBL] [Abstract][Full Text] [Related]
5. Bioassay-guided isolation and characterization of active antiplasmodial compounds from Murraya koenigii extracts against Plasmodium falciparum and Plasmodium berghei.
Kamaraj C; Rahuman AA; Roopan SM; Bagavan A; Elango G; Zahir AA; Rajakumar G; Jayaseelan C; Santhoshkumar T; Marimuthu S; Kirthi AV
Parasitol Res; 2014 May; 113(5):1657-72. PubMed ID: 24638906
[TBL] [Abstract][Full Text] [Related]
6. Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo.
Vivas L; Rattray L; Stewart L; Bongard E; Robinson BL; Peters W; Croft SL
Acta Trop; 2008 Mar; 105(3):222-8. PubMed ID: 18279817
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo anti-malarial activity of novel harmine-analog heat shock protein 90 inhibitors: a possible partner for artemisinin.
Bayih AG; Folefoc A; Mohon AN; Eagon S; Anderson M; Pillai DR
Malar J; 2016 Dec; 15(1):579. PubMed ID: 27903279
[TBL] [Abstract][Full Text] [Related]
8. Viability Screen of LOPAC
Tong JX; Ang SEL; Tan EHN; Tan KSW
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718250
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.
Le Bihan A; de Kanter R; Angulo-Barturen I; Binkert C; Boss C; Brun R; Brunner R; Buchmann S; Burrows J; Dechering KJ; Delves M; Ewerling S; Ferrer S; Fischli C; Gamo-Benito FJ; Gnädig NF; Heidmann B; Jiménez-Díaz MB; Leroy D; Martínez MS; Meyer S; Moehrle JJ; Ng CL; Noviyanti R; Ruecker A; Sanz LM; Sauerwein RW; Scheurer C; Schleiferboeck S; Sinden R; Snyder C; Straimer J; Wirjanata G; Marfurt J; Price RN; Weller T; Fischli W; Fidock DA; Clozel M; Wittlin S
PLoS Med; 2016 Oct; 13(10):e1002138. PubMed ID: 27701420
[TBL] [Abstract][Full Text] [Related]
10. Pre-clinical study of iron oxide nanoparticles fortified artesunate for efficient targeting of malarial parasite.
Kannan D; Yadav N; Ahmad S; Namdev P; Bhattacharjee S; Lochab B; Singh S
EBioMedicine; 2019 Jul; 45():261-277. PubMed ID: 31255656
[TBL] [Abstract][Full Text] [Related]
11. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
Sante; 2008; 18(1):43-7. PubMed ID: 18684691
[TBL] [Abstract][Full Text] [Related]
12. Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone.
Skinner-Adams TS; Fisher GM; Riches AG; Hutt OE; Jarvis KE; Wilson T; von Itzstein M; Chopra P; Antonova-Koch Y; Meister S; Winzeler EA; Clarke M; Fidock DA; Burrows JN; Ryan JH; Andrews KT
Commun Biol; 2019; 2():166. PubMed ID: 31069275
[TBL] [Abstract][Full Text] [Related]
13. Antimalarial activity of Malaria Box Compounds against Plasmodium falciparum clinical isolates.
Chirawurah JD; Ansah F; Nyarko PB; Duodu S; Aniweh Y; Awandare GA
Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):399-406. PubMed ID: 29128848
[TBL] [Abstract][Full Text] [Related]
14. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
[TBL] [Abstract][Full Text] [Related]
15. Antiplasmodial activity, in vivo pharmacokinetics and anti-malarial efficacy evaluation of hydroxypyridinone hybrids in a mouse model.
Dambuza NS; Smith P; Evans A; Norman J; Taylor D; Andayi A; Egan T; Chibale K; Wiesner L
Malar J; 2015 Dec; 14():505. PubMed ID: 26671222
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antimalarial activity, and intracellular targets of MEFAS, a new hybrid compound derived from mefloquine and artesunate.
de Pilla Varotti F; Botelho AC; Andrade AA; de Paula RC; Fagundes EM; Valverde A; Mayer LM; Mendonça JS; de Souza MV; Boechat N; Krettli AU
Antimicrob Agents Chemother; 2008 Nov; 52(11):3868-74. PubMed ID: 18710907
[TBL] [Abstract][Full Text] [Related]
17. Protective activity of biflavanones from Garcinia kola against Plasmodium infection.
Konziase B
J Ethnopharmacol; 2015 Aug; 172():214-8. PubMed ID: 26129936
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
[TBL] [Abstract][Full Text] [Related]
19. Assessment of in vitro and in vivo antimalarial efficacy and GC-fingerprints of selected medicinal plant extracts.
Sachdeva C; Mohanakrishnan D; Kumar S; Kaushik NK
Exp Parasitol; 2020 Dec; 219():108011. PubMed ID: 33010286
[TBL] [Abstract][Full Text] [Related]
20. Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum.
Duffey M; Sanchez CP; Lanzer M
Malar J; 2018 Mar; 17(1):121. PubMed ID: 29558913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
